中国实用口腔科杂志 ›› 2011, Vol. 4 ›› Issue (05): 299-300.

• 论著 • 上一篇    下一篇

利巴韦林联合地塞米松治疗贝尔麻痹疗效分析

  

  1. 中山大学附属第五医院 a 神经内科,b 口腔颌面外科,广东  519000
  • 收稿日期:2011-03-07 修回日期:2011-04-10 出版日期:2011-05-15 发布日期:2011-07-04

  • Received:2011-03-07 Revised:2011-04-10 Online:2011-05-15 Published:2011-07-04

摘要:

目的    研究利巴韦林和地塞米松在贝尔麻痹治疗中的应用效果。方法    选取2002年8月至2010年10月中山大学附属第五医院神经内科和口腔科收治的贝尔麻痹患者60例,按就诊顺序随机分为A、B两组,每组30例。A组给予利巴韦林和地塞米松联合治疗,B组仅给予地塞米松治疗。两组患者治疗前、后均以Portmann简易评分法评分,并进行比较分析。结果    治疗前,60例患者疗效评分均<9分。治疗后,A组满意率为80.33%,明显高于B组(60.00%),且差异有统计学意义(P < 0.05)。结论    应用利巴韦林联合地塞米松治疗贝尔麻痹效果良好,值得临床推广。

关键词: 贝尔麻痹, 利巴韦林, 地塞米松

Abstract:

Objective    To investigate the effect of Ribovirin and Dexamethasone in the treatment for Bell paralysis. Methods    A total of 60 patients with Bell paralysis were randomly divided into two groups:A and B,each with 30 patients. Treatment group(A) was treated by Ribovirin and Dexamethasone;control group(B) was treated by Dexamethasone only. Results    The 30 cases of Bell paralysis by Ribovirin and Dexamethasone therapy recovered better;therapeutic efficacy was better in treatment group than in control group, P < 0.05,there being statistical significance in the two groups. Conclusion    The effect of Ribovirin and Dexamethasone in the treatment for Bell paralysis is good,whith can be generalized.

Key words: Bell paralysis;Ribovirin;Dexamethasone